BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 165666)

  • 1. Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.
    Weiss B
    Adv Cyclic Nucleotide Res; 1975; 5():195-211. PubMed ID: 165666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterases.
    Appleman MM; Thompson WJ; Russell TR
    Adv Cyclic Nucleotide Res; 1973; 3():65-98. PubMed ID: 4361529
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
    Hidaka H; Asano T; Shimamoto T
    Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Ca++ on cyclic nucleotide phosphodiesterases of superior cervical ganglion.
    Boudreau RJ; Drummond GI
    J Cyclic Nucleotide Res; 1975; 1(4):219-28. PubMed ID: 177462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cyclic AMP phosphodiesterase by a new vitamin E derivative.
    Sakai T; Okano T; Makino H; Tsudzuki T
    J Cyclic Nucleotide Res; 1976; 2(3):163-70. PubMed ID: 180065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
    Alvarez R; Sette C; Yang D; Eglen RM; Wilhelm R; Shelton ER; Conti M
    Mol Pharmacol; 1995 Oct; 48(4):616-22. PubMed ID: 7476886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple forms of cyclic 3',5'-AMP phosphodiesterase of rat cerebrum and cloned astrocytoma and neuroblastoma cells.
    Uzunov P; Shein HM; Weiss B
    Neuropharmacology; 1974 May; 13(5):377-91. PubMed ID: 4370207
    [No Abstract]   [Full Text] [Related]  

  • 11. A kinetic analysis of the cyclic nucleotide phosphodiesterase regulation by the endogenous protein activator. A study of rat brain and frog sympathetic chain.
    Uzunov P; Lehne R; Revuelta AV; Gnegy ME; Costa E
    Biochim Biophys Acta; 1976 Feb; 422(2):326-34. PubMed ID: 174744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
    Minneman KP
    J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide phosphodiesterases in neoplastic and nonneoplastic human mammary tissues.
    Singer AL; Sherwin RP; Dunn AS; Appleman MM
    Cancer Res; 1976 Jan; 36(1):60-6. PubMed ID: 174814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
    Gupta R; Kumar G; Kumar RS
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterase activities of the fetal and mature human cerebral cortex.
    Kang ES
    Pediatr Res; 1977 May; 11(5):655-63. PubMed ID: 193085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.
    Kumar S; Becker G; Prasad KN
    Cancer Res; 1975 Jan; 35(1):82-7. PubMed ID: 234030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
    Levin RM; Weiss B
    Mol Pharmacol; 1977 Jul; 13(4):690-7. PubMed ID: 18661
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.